The Impact of COVID-19 Pandemic and Lockdown Restrictions on Cardiac Implantable Device Recipients with Remote Monitoring

Diemberger, Igor; Vicentini, Alessandro; Cattafi, Giuseppe; Ziacchi, Matteo; Iacopino, Saverio; Morani, Giovanni; Pisanó, Ennio; Molon, Giulio; Giovannini, Tiziana; Russo, Antonio Dello; Boriani, Giuseppe; Bertaglia, Emanuele; Biffi, Mauro; Bongiorni, Maria Grazia; Rordorf, Roberto; Zucchelli, Giulio

doi:10.3390/jcm10235626

Cited by 9 publications

(7 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[66][67][68][69][70][71][72][73][74][75][76][77]; not acute COVID-19 population-Refs. [78][79][80][81][82][83][84][85][86][87][88][89][90]; not in English or Italian-Refs. [49,50]; study design-Refs.…”

Section: Study Selectionmentioning

confidence: 99%

See 1 more Smart Citation

Autonomic Dysfunction during Acute SARS-CoV-2 Infection: A Systematic Review

Scala

Rizzo

Bellavia

et al. 2022

JCM

View full text Add to dashboard Cite

Although autonomic dysfunction (AD) after the recovery from Coronavirus disease 2019 (COVID-19) has been thoroughly described, few data are available regarding the involvement of the autonomic nervous system (ANS) during the acute phase of SARS-CoV-2 infection. The primary aim of this review was to summarize current knowledge regarding the AD occurring during acute COVID-19. Secondarily, we aimed to clarify the prognostic value of ANS involvement and the role of autonomic parameters in predicting SARS-CoV-2 infection. According to the PRISMA guidelines, we performed a systematic review across Scopus and PubMed databases, resulting in 1585 records. The records check and the analysis of included reports’ references allowed us to include 22 articles. The studies were widely heterogeneous for study population, dysautonomia assessment, and COVID-19 severity. Heart rate variability was the tool most frequently chosen to analyze autonomic parameters, followed by automated pupillometry. Most studies found ANS involvement during acute COVID-19, and AD was often related to a worse outcome. Further studies are needed to clarify the role of autonomic parameters in predicting SARS-CoV-2 infection. The evidence emerging from this review suggests that a complex autonomic nervous system imbalance is a prominent feature of acute COVID-19, often leading to a poor prognosis.

show abstract

Section: Study Selectionmentioning

confidence: 99%

“…Reports excluded: Not formal assessment of dysautonomia-Refs [66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][49,50]…”

mentioning

confidence: 99%

Autonomic Dysfunction during Acute SARS-CoV-2 Infection: A Systematic Review

Scala

Rizzo

Bellavia

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

Section: Ventricular Arrythmias and Sudden Cardiac Deathmentioning

confidence: 99%

“…A study from Italy, enrolling 696 patients with cardiac devices, reported on the effects of COVID-19 and demonstrated a significant increase in the burdens of ventricular tachycardia, associated with a decrease in physical activity and heart rate variability [ 76 ]. Considering the trend of reduced physical activity in subjects with post-COVID conditions, this phenomenon appears to be associated with a direct impact of the reduced physical activity on ventricular arrythmias [ 76 ]. Another multicenter trial studying 204 post-COVID patients in a 3-month follow-up after hospitalization detected mildly impaired right ventricular function and higher rates of ventricular arrhythmias compared with a control group [ 77 ].…”

Section: Ventricular Arrythmias and Sudden Cardiac Deathmentioning

confidence: 99%

Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment

Huseynov

Akın

Duerschmied

et al. 2023

Viruses

View full text Add to dashboard Cite

An increase in post-COVID patients with late sequelae of acute COVID-19 infection is emerging as an ongoing challenge for physicians and healthcare professionals. Since the beginning of the pandemic, it has rapidly become evident that the acute infection is not limited to the respiratory tract but that several organs, including the cardiovascular system, can be affected. Moreover, in a significant proportion of patients (ranging from about 10 to up to 50%) with former COVID-19, cardiopulmonary symptoms such as dyspnea, palpitations, restricted physical capacity, and cardiac arrhythmias can persist weeks and months after the acute SARS-CoV-2 infection. The spectrum of COVID-19-associated arrhythmias is rather wide, most likely due to various pathomechanisms. In this article, the prevalence of cardiac arrhythmias and underlying pathologies are reviewed, including direct myocardial injury and abnormal consequences with an impact on cardiac electric instability. The hyperinflammatory reaction of the host immune system is specifically considered. Moreover, several distinct rhythm disorders occurring in post-COVID patients are discussed with regard to their clinical management.

show abstract

“… 2 , 13 , 14 As a consequence, there was an acceleration in the development of telemedicine and the use of RM in order to follow cardiac patients at distance. 10 , 11 , 15–17 …”

Section: Rm and Covid-19 Pandemicmentioning

confidence: 99%

Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe

et al. 2022

Self Cite

View full text Add to dashboard Cite

Remote monitoring (RM) of cardiac implantable electrical devices (CIEDs) is currently proposed as a standard of care for CIEDs follow-up, as recommended by major cardiology societies worldwide. By detecting a series of relevant device and patient-related parameters, RM is a valuable option for early detection of CIEDs' technical issues, as well as changes in parameters related to cardio-respiratory functions. Moreover, RM may allow longer spacing between in-office follow-ups and better organization of in-hospital resources. Despite these potential advantages, resulting in improved patient safety, we are still far from a widespread diffusion of RM across Europe. Reimbursement policies across Europe still show an important heterogeneity and have been considered as an important barrier to full implementation of RM as a standard for the follow-up of all the patients with pacemakers, defibrillators, devices for cardiac resynchronization, or implantable loop recorders. Indeed, in many countries, there are still inertia and unresponsiveness to the request for widespread implementation of RM for CIEDs, although an improvement was found in some countries as compared to years ago, related to the provision of some form of reimbursement. As a matter of fact, the COVID-19 pandemic has promoted an increased use of digital health for connecting physicians to patients, even if digital literacy may be a limit for the widespread implementation of telemedicine. CIEDs have the advantage of making possible RM with an already defined organization and reliable systems for data transmissions that can be easily implemented as a standard of care for present and future cardiology practice.

show abstract

The Impact of COVID-19 Pandemic and Lockdown Restrictions on Cardiac Implantable Device Recipients with Remote Monitoring

Cited by 9 publications

References 22 publications

Autonomic Dysfunction during Acute SARS-CoV-2 Infection: A Systematic Review

Autonomic Dysfunction during Acute SARS-CoV-2 Infection: A Systematic Review

Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment

Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe

Contact Info

Product

Resources

About